Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study.

Liang XieQinhan WuQunying LinXuhui LiuWeihua LinShengyu HaoWeiping HuGui-Ling XiangHongzhou LuShan-Qun Li

Published in: Therapeutic advances in respiratory disease (2020)

COVID-19 might target adaptive immunity and cause a decrease in lymphocytes, especially T cells and subsets. Physicians should pay close attention to the adaptive immunity of patients upon admission. Monitoring NLR, T lymphocytes, and subsets would help physicians with the proper diagnosis and treatment of COVID-19.The reviews of this paper are available via the supplemental material section.

Keyphrases

coronavirus disease
sars cov
primary care
peripheral blood
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
peritoneal dialysis
respiratory syndrome coronavirus
oxidative stress
randomized controlled trial
patient reported outcomes